Literature DB >> 7408117

Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs.

J P Montani, J F Liard, J Schoun, J Möhring.   

Abstract

The possibility that vasopressin plays a role in cardiovascular control arouses increasing interest. We studied in unanesthetized dogs the hemodynamic consequences of 1-hour vasopressin infusions that modified plasma concentrations over a range similar to that found in physiological situations. We also examined the cardiovascular events following the stimulation of endogenous vasopressin release by an increase in plasma osmolality. In dogs with baroreceptor reflexes intact, vasopressin infusions which increased plasma vasopressin concentration by 2-20 fmol/ml did not affect mean arterial pressure. However, they significantly decreased cardiac ouput (measured by an electromagnetic flowmeter) and increased total peripheral resistance. After baroreceptor denervation, vasopressin infusion rates as low as 40 fmol/kg per min (0.017 microU/kg per min) led to an increase in mean arterial pressure. Cardiac output was unaffected until much higher infusion rates were used. Changes in total peripheral resistance were very similar to those calculated in dogs with intact baroreceptors. The release of vasopressin following infusions of hypertonic solutions either intravenously or into a carotid artery induced detectable hemodynamic changes which appeared in many respects similar to those following low infusion rates of vasopressin. We conclude that physiological plasma concentrations of vasopressin have hemodynamic effects even though they do not normally modify arterial pressure, presumably because of some particular interaction of vasopressin with the baroreceptor reflex.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408117     DOI: 10.1161/01.res.47.3.346

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

1.  Sensitization of aortic and cardiac baroreceptors by arginine vasopressin in mammals.

Authors:  F M Abboud; P E Aylward; J S Floras; B N Gupta
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

2.  Hemodynamic and hormonal responses to 8-arginine-vasopressin in healthy man: effects of indomethacin.

Authors:  K Glänzer; B Prüssing; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1982-10-01

3.  The effects and interactions of angiotensin and vasopressin on the heart of unanaesthetized sheep.

Authors:  A C Caine; E R Lumbers; I A Reid
Journal:  J Physiol       Date:  1985-10       Impact factor: 5.182

4.  Effect of vasopressin on phasic coronary blood flow.

Authors:  J B Michel; A Tedgui; A Bardou; B Levy
Journal:  Basic Res Cardiol       Date:  1985 May-Jun       Impact factor: 17.165

5.  Clinical settings and vasopressin function in hyponatraemic children.

Authors:  M Gerigk; M Bald; F Feth; W Rascher
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

6.  [Cardiovascular effect of the antidiuretic hormone arginine vasopressin].

Authors:  W Rascher
Journal:  Klin Wochenschr       Date:  1985-10-01

Review 7.  Role of vasopressin in the management of septic shock.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Intensive Care Med       Date:  2004-04-21       Impact factor: 17.440

8.  Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.

Authors:  Andrea Morelli; Monica Rocco; Giorgio Conti; Alessandra Orecchioni; Andrea De Gaetano; Giuliana Cortese; Flaminia Coluzzi; Enrico Vernaglione; Paolo Pelaia; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

9.  Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells.

Authors:  P R Standley; F Zhang; J L Ram; M B Zemel; J R Sowers
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Aortic baroreceptor characteristics in dogs with chronic high output failure.

Authors:  M J Niebauer; M J Holmberg; I H Zucker
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.